Apotex Seeking FDA Reconsideration Of Normocarb Drug Designation
This article was originally published in The Gray Sheet
Executive Summary
Apotex wants FDA to designate its Normocarb pre-filter hemofiltration solution as a device instead of a drug in the hope that it can be cleared through the 510(k) process
You may also be interested in...
Congressional Inquiry Into FDA Combo Product Policy Needed – Consultant
R. Sheridan Consulting is urging Congress to review FDA's criteria for determining whether a combination product should be regulated as a drug or a device
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.